CompuGroup Medical SE KGaA

EHR Mandates And Digitalization Will Expand Health IT Markets

AnalystHighTarget

Not Invested

Consensus Narrative from 2 Analysts

Published

01 Aug 25

AnalystHighTarget's Fair Value

€29.00

21.9% undervalued

10 Sep

€22.66

66.3%

You can edit this narrative until Aug 1 9:22 PM. Then, changes will post as Updates.

Author's Valuation

€29.0

21.9% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

€29

21.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

2.22%

Healthtech revenue growth rate

5.11%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.16%

Calculation

€108.31m

Earnings '28

16.79x

PE Ratio '28

€1.82b

Market Cap '28

€1.82b

Market Cap '28

51.74m

No. shares '28

€35.15

Share Price '28

€35.15 Share Price '28

Discounted to 2025 @ 7.13% p.a.

€28.59

Fair Value '25